Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
Tenaya Therapeutics, a clinical-stage biotech focused on gene therapies for heart disease, announced its participation in the Jefferies Global Healthcare Conference with CEO Faraz Ali presenting on June 4, 2026. The company highlighted its pipeline including gene therapies targeting hypertrophic cardiomyopathy and arrhythmogenic right ventricular c…